Local Autoantibody Production in Subarachnoid Neurocysticercosis via Molecular Mimicry

Overview

This study demonstrates that patients with subarachnoid neurocysticercosis (SANCC) produce local cerebrospinal fluid (CSF) autoantibodies targeting human proteins annexin A8 (ANXA8) and BAP18. These autoantibodies cross-react with homologous proteins from Taenia solium, suggesting molecular mimicry drives local autoantibody production contributing to SANCC pathology.

Background

Neurocysticercosis (NCC) is a CNS infection caused by Taenia solium larvae, with subarachnoid neurocysticercosis (SANCC) representing a severe form involving cyst growth in subarachnoid spaces. SANCC leads to chronic meningitis with relapsing inflammation and significant morbidity and mortality. Autoantibodies have been implicated in various CNS inflammatory diseases, but their role in SANCC remains unclear. This study investigates the presence and potential molecular mimicry-driven generation of autoantibodies in SANCC.

Data Highlights

Key Findings

• CSF from SANCC patients shows significant IgG autoantibody reactivity against human ANXA8 and BAP18 compared to uninfected controls.
• Taenia solium homologues of ANXA8 and BAP18 proteins were identified, supporting molecular mimicry as a mechanism.
• Immunoblotting with antihuman ANXA8 antibody identified Taenia solium annexin B3 protein.
• Antihuman BAP18 antibody recognized cestode enzymes involved in metabolic pathways.
• Local CSF antibody production in SANCC likely targets both parasite and human homologous proteins, potentially contributing to disease pathology.

Clinical Implications

Recognition of autoantibody production driven by molecular mimicry in SANCC suggests that immune-mediated mechanisms contribute to disease progression beyond direct parasitic effects. This insight may inform future therapeutic strategies targeting aberrant immune responses in SANCC. Clinicians should consider the potential role of autoimmunity when managing SANCC patients, especially in chronic or relapsing cases.

Conclusion

The study provides evidence that molecular mimicry between Taenia solium proteins and human CNS antigens drives local autoantibody production in SANCC, which may play a role in disease pathogenesis. Understanding these immune mechanisms could guide improved diagnostic and therapeutic approaches.

References

1. Major Article, Tropical and Emerging Infectious Diseases -- Local Autoantibody Production in Subarachnoid Neurocysticercosis Driven by Molecular Mimicry